Ieq Capital LLC reduced its holdings in Tenet Healthcare Corporation (NYSE:THC – Free Report) by 16.1% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 52,131 shares of the company’s stock after selling 10,019 shares during the quarter. Ieq Capital LLC’s holdings in Tenet Healthcare were worth $13,323,000 as of its most recent filing with the Securities and Exchange Commission.
Several other large investors have also recently added to or reduced their stakes in THC. Talon Private Wealth LLC increased its position in Tenet Healthcare by 35.4% during the second quarter. Talon Private Wealth LLC now owns 23,097 shares of the company’s stock worth $4,321,000 after purchasing an additional 6,044 shares during the last quarter. Counterpoint Mutual Funds LLC purchased a new stake in shares of Tenet Healthcare during the 3rd quarter valued at $9,593,000. CX Institutional acquired a new stake in shares of Tenet Healthcare during the 3rd quarter worth $6,415,000. Public Employees Retirement System of Ohio acquired a new stake in shares of Tenet Healthcare during the 2nd quarter worth $10,144,000. Finally, VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Tenet Healthcare in the 2nd quarter worth $5,504,000. 95.44% of the stock is currently owned by hedge funds and other institutional investors.
Tenet Healthcare News Summary
Investors following THC have been watching these news items:
- Positive Sentiment: Zacks Research raised its EPS forecasts across several quarters and full years. Its FY2027 estimate increased to $19.77 from $18.91, and its FY2028 estimate rose to $20.98 from $20.09. Higher analyst expectations may support investor sentiment by suggesting improved earnings prospects. Tenet Healthcare analyst estimates
- Positive Sentiment: A separate Zacks article characterized THC as a top-ranked momentum stock, a potentially favorable signal for investors focused on price trends. Zacks momentum-stock article
- Neutral Sentiment: Despite the estimate increases, Zacks Research maintained a “Hold” rating, indicating it did not make a more bullish recommendation. Tenet Healthcare analyst information
Wall Street Analysts Forecast Growth
THC has been the subject of several recent research reports. Truist Financial reiterated a “buy” rating and issued a $305.00 price target (up from $290.00) on shares of Tenet Healthcare in a report on Tuesday, November 3rd. BMO Capital Markets initiated coverage on shares of Tenet Healthcare in a research report on Tuesday, September 22nd. They issued a “market perform” rating and a $265.00 target price for the company. Royal Bank Of Canada lifted their target price on Tenet Healthcare from $283.00 to $304.00 and gave the stock an “outperform” rating in a research report on Monday, November 2nd. Guggenheim lowered their price target on Tenet Healthcare from $307.00 to $306.00 and set a “buy” rating for the company in a report on Friday, October 30th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a research report on Friday, October 2nd. Nineteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $296.65.
Check Out Our Latest Analysis on Tenet Healthcare
Tenet Healthcare Stock Performance
Shares of NYSE THC opened at $263.34 on Friday. The company has a quick ratio of 1.52, a current ratio of 1.58 and a debt-to-equity ratio of 1.76. The firm’s 50-day moving average price is $268.86 and its two-hundred day moving average price is $226.99. Tenet Healthcare Corporation has a 52-week low of $157.58 and a 52-week high of $301.44. The stock has a market capitalization of $20.96 billion, a P/E ratio of 7.64, a P/E/G ratio of 1.56 and a beta of 1.20.
Tenet Healthcare (NYSE:THC – Get Free Report) last posted its earnings results on Thursday, October 29th. The company reported $6.64 EPS for the quarter, beating the consensus estimate of $4.68 by $1.96. The company had revenue of $6.28 billion during the quarter, compared to analyst estimates of $5.49 billion. Tenet Healthcare had a return on equity of 28.22% and a net margin of 13.09%. The business’s revenue was up 6.5% compared to the same quarter last year. During the same period in the prior year, the company earned $3.70 earnings per share. As a group, sell-side analysts forecast that Tenet Healthcare Corporation will post 22.32 earnings per share for the current year.
Insider Activity
In other news, Director Cecil D. Haney sold 1,300 shares of the business’s stock in a transaction on Monday, August 24th. The shares were sold at an average price of $278.03, for a total transaction of $361,439.00. Following the completion of the transaction, the director owned 12,553 shares of the company’s stock, valued at approximately $3,490,110.59. The trade was a 9.38% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director J. Robert Kerrey sold 12,010 shares of the stock in a transaction dated Monday, September 14th. The stock was sold at an average price of $263.72, for a total transaction of $3,167,277.20. Following the completion of the sale, the director directly owned 4,794 shares in the company, valued at approximately $1,264,273.68. This trade represents a 71.47% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 99,462 shares of company stock worth $27,081,234 over the last 90 days. Insiders own 0.97% of the company’s stock.
About Tenet Healthcare
Tenet Healthcare Corporation is a U.S.-based healthcare services company that operates acute care hospitals and provides related inpatient and outpatient services. Its hospitals offer services across areas such as emergency care, surgery, imaging and specialty treatment. Through its subsidiary United Surgical Partners International (USPI), Tenet also operates ambulatory surgery centers and surgical hospitals, providing outpatient surgical and procedural care. The company’s Conifer Health Solutions business provides revenue cycle management and other administrative services to healthcare providers.
Read More
- Five stocks we like better than Tenet Healthcare
- MarketBeat Week in Review – 11/16 – 11/20
- Survey Reveals: How Much Would People Pay for Ribeye Before Giving It Up? [2026]
- If NVIDIA Tightens Its Wallet, These 3 Stocks Could Feel It
- 3 Dividend ETFs Offering Steadier Footing in a Shaky Market
Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Corporation (NYSE:THC – Free Report).
Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
